327 Draft term sheet discussed with Sanofi GSK at the JNT during the exploratory talks 22 06 20 Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →Start / Quellenregister
Dokumentation
Quellenregister
1852 Belegkennungen mit Originaladressen und Fundstellen. Historische Fassungen werden nach ihrem eigenen Datum geführt.
Die Originale und ihre Belegkennungen.
328 Sanofi GSK pre reads exploratory talks 24 06 20 redacted s.pdf
1 PDF-Seiten
Quelle öffnen →329 Sanofi GSK presentation exploratory talks 25 06 20 redacted s.pdf
2 PDF-Seiten
Quelle öffnen →33 Email Agenda 17 September 2020 Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →330 2 Answers to your questions list guiding you in the Term Sheet version 2 Redacted s.pdf
3 PDF-Seiten
Quelle öffnen →330 3 Cover Letter explaining the principles of the revised Term Sheet version 2 Redacted s.pdf
4 PDF-Seiten
Quelle öffnen →330 Draft term sheet discussed with Sanofi GSK at the JNT during the exploratory talks 29 06 20 Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →331 1 Email 8 Draft term sheet discussed with Sanofi GSK at the JNT during the exploratory talks 10 07 20 Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →331 Draft term sheet discussed with Sanofi GSK at the JNT during the exploratory talks 10 07 20Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →332 Draft term sheet discussed with Sanofi GSK at the JNT during the exploratory talks 22 07 20.pdf
2 PDF-Seiten
Quelle öffnen →333 Draft term sheet discussed with Sanofi GSK at the JNT during the exploratory talks 29 07 20 Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →334 Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID 19 Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →335 Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID 19 redacted s.pdf
2 PDF-Seiten
Quelle öffnen →336 1 meeting with SANOFI on APIS on 2 04 bto 2 Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →336 Ares 2020 2270849 meeting with SANOFI on APIS on 2 04 bto 2 Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →337 Follow up questionnaire sent to GSK redacted s.pdf
1 PDF-Seiten
Quelle öffnen →338 skype meeting with GSK 12052020 vaccines Redacted s.pdf
4 PDF-Seiten
Quelle öffnen →339 Novavax exploratory talks outcome 11 12 2020 Redacted s.pdf
3 PDF-Seiten
Quelle öffnen →34 1 Email SB Minutes 17 September 2020 Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →34 SB minutes 17 September 2020 Redacted s.pdf
3 PDF-Seiten
Quelle öffnen →340 Novavax exploratory talks with JNT Indemnity Liability Comments 5 11 2020 Redacted s.pdf
5 PDF-Seiten
Quelle öffnen →341 Novavax exploratory talks with JNT 6 12 2020 email Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →342 Novavax exploratory talks with JNT 9 12 2020 email Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →343 Novavax exploratory talks with JNT 25 08 2020 email Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →344 Novavax exploratory talks with JNT 26 08 2020 email Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →345 Novavax exploratory talks with JNT Idemnification 19 09 2020 Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →346 1 Invitation to tender Tender Specifications Vaccins COVID19 5 pdf Redacted s.pdf
49 PDF-Seiten
Quelle öffnen →346 2 Invitation to tender Annex 6 Financial offer xlsx pdf Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →346 Invitation to tender SANTE2020C3087 Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →347 Q1 RE Call for tenders SANTE2020C3087 for the development production priority purchasing options and supply of Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →348 Answer to Q1 part 1 Redacted s.pdf
3 PDF-Seiten
Quelle öffnen →349 Answer to Q1 part 2 RE SANTE2020C3087 question on deadline Redacted s.pdf
7 PDF-Seiten
Quelle öffnen →35 1 Agenda SB Meeting 18 September 2020 Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →35 Email SB Meeting 18 September 2020 Redacted s.pdf
2 PDF-Seiten
Quelle öffnen →350 Tender submission Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →351 Draft APA based on your tender Redacted s.pdf
1 PDF-Seiten
Quelle öffnen →